Volume | 5,323,123 |
|
|||||
News | (1) | ||||||
Day High | 169.99 | Low High |
|||||
Day Low | 161.375 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Zoetis Inc | ZTS | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
163.10 | 161.375 | 169.99 | 167.23 | 158.50 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
74,089 | 5,323,123 | US$ 166.98 | US$ 888,863,436 | - | 144.80 - 201.92 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:59:52 | 1 | US$ 167.11 | USD |
Zoetis (ZTS) Options Flow Summary
Zoetis Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
76.57B | 457.87M | - | 8.54B | 2.34B | 5.12 | 32.67 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Zoetis News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZTS Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 150.61 | 169.99 | 150.04 | 157.82 | 4,404,183 | 15.89 | 10.55% |
1 Month | 165.18 | 169.99 | 144.80 | 154.63 | 4,536,062 | 1.32 | 0.80% |
3 Months | 196.08 | 200.5341 | 144.80 | 169.64 | 3,709,594 | -29.58 | -15.09% |
6 Months | 153.94 | 201.92 | 144.80 | 175.39 | 2,734,149 | 12.56 | 8.16% |
1 Year | 179.48 | 201.92 | 144.80 | 175.41 | 2,333,439 | -12.98 | -7.23% |
3 Years | 174.70 | 249.27 | 124.1483 | 177.37 | 2,071,993 | -8.20 | -4.69% |
5 Years | 100.265 | 249.27 | 90.14 | 161.12 | 2,045,518 | 66.24 | 66.06% |
Zoetis Description
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit. |